Rein 3D PRINT MECHANICS
ConditionKidney Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Bordeaux
About this trial
The goal of this innovative project is to evaluate the correspondence between several imaging modalities for characterizing the elasticity of healthy and pathological renal tissue which could help improve the realism of 3D prints used by urological surgeons and allow the identification of new, complementary imaging biomarkers. The main objective is to develop a predictive model of the biomechanical properties of normal and pathological kidney tissue, as assessed by the reference method (Magnetic Resonance (MR)-elastography).
Eligibility criteria
Qualifiers
Adult patients (≥ 18 years of age)
Scheduled for surgical management with nephrectomy for kidney tumor in the urology department of Bordeaux University Hospital
CT scan available or scheduled for surgery
Consent expressed for integration of the UroCCR database
Disqualifiers
- Pregnant or breast-feeding women
Contraindication to MRI (Magnetic Resonance Imaging)
Contraindication to injection of gadoline contrast agents
Biopsy performed within 15 days prior to MRI, CT and ultrasound scans (risk of artifactual alteration, via iatrogenic hemorrhagic changes, of the biomechanical properties of the renal tumor and parenchyma).
Trial design
Treatments tested in this trial
- MR-elastography exam
- Ultrasound exam
Treatment groups
50 Participants
are divided into 1 treatment groupLocations
1CHU de Bordeaux33076, Bordeaux France
Sponsors and collaborators
University Hospital, Bordeaux
Lead sponsor
Sophia Genetics SAS
Collaborator
Source ClinicalTrials.gov